87 companies
Clessidra Capital Partners 3 Fund
Italy
Inactive
Co SpA Zambon
DR 3 S.r.l.
Netherlands
Inactive
Davide Campari-milano N.V.
Italy
Deutsche Bank S.p.A
DIA-IM
Diasorin S.p.A.
Diebold Nixdorf S.r.l.
Diego Della Valle & C. S.a.p.a.
Italy
Inactive
Dragon Spac S.p.a.
Italy
Edmond De Rothschild
Italy
Inactive
Enel Energy Europe S.r.l.
Italy
Inactive
Esse Effe S.p.A.
Italy
ExOne Italy S.r.l
Pennsylvania
Inactive
FNDSF
Fiat Industrial SPA
Italy
Inactive
NASDAQ
Fidia Farmaceutici S.p.A.
Italy
Inactive
Fin Posillipo S.p.A.
Italy
Inactive
FinSirton S.p.A.
Italy
Inactive
FinecoBank SpA
Italy
Inactive
Gardant Investor SGR S.p.A., in its Capacity as Management Co of Caesar Fund
Italy
GNTA
Genenta Science SpA
cancer immunotherapy - our gene therapy science to treat cancer we develop a gene transfer strategy into autologous hematopoietic stem/progenitor cells (hspcs) to target interferon-α expression to tumor-infiltrating monocytes/macrophages.
Italy
NASDAQ